5:53 PM
 | 
Jun 02, 2016
 |  BC Extra  |  Financial News

Ablynx raises EUR 74.2 million

Antibody company Ablynx N.V. (Euronext:ABLX) raised EUR 74.2 million ($82.5 million) through a private placement of 5.5 million shares at EUR 13.40. The price is a 6% discount to Ablynx' close of EUR 14.30 on Wednesday, before the deal was announced. JPMorgan, Jefferies and KBC Securities...

Read the full 212 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >